Stay updated on Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, indicating a small update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-06-05T11:25:02.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new Revision: v3.5.4 entry was added and the previous Revision: v3.5.3 entry was removed, updating the page to reflect the latest release version.
    Difference
    0.0%
    Check dated 2026-05-14T23:01:19.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.5.2 to v3.5.3, signaling an updated release of the page's documentation/assets. This is an administrative update and does not reflect changes to study content or data.
    Difference
    0.0%
    Check dated 2026-04-30T17:18:44.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed on the page, replacing the previous v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T11:15:49.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Updated two location entries from Napoli, Italy, 80131 and 87100 to Naples, Italy, 80131 and 87100.
    Difference
    0.1%
    Check dated 2026-03-25T21:24:37.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:46.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.